Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours Β· Estimated delivery Aug 31 - Sep 5
Research communications in molecular pathology and pharmacology
doi:10.2337/dc22-Sint
Retatrutide works as a triple receptor agonist, targeting three key hormonal pathways simultaneously: [1] [4] GLP-1 (glucagon-like peptide-1): Is thought to reduce appetite and slow gastric emptying GIP (glucose-dependent insulinotropic polypeptide): Is thought to enhance insulin secretion and may influence fat metabolism, though human evidence remains limited Glucagon receptor: Has been observed in early studies to increase energy expenditure and promote fat breakdown, though the clinical significance in humans is still being established This triple-action mechanism distinguishes retatrutide from currently approved dual or single agonists
This creates a vicious cycle of weight gain and inflammation
Neuroinflammation in dementia: A meta-analysis of PET imaging studies
US$ 27.58
US$ 23.53
US$ 22.29
US$ 28.56
US$ 28.55
US$ 29.52
US$ 21.24
US$ 28.79
US$ 23.93
US$ 22.38
US$ 23.28
US$ 20.82
